Table 2. Microbiological findings.
| Characteristic | Colonized | Noncolonized |
|---|---|---|
| Number of patients (n, %) | 90 (40.9) | 130 (59.1) |
| VRE (n, %) | 67 (74.4) | 0 |
| ESBL/±FQ (n, %) | 18 (20) | 0 |
| CRE (n, %) | 12 (13.3) | 0 |
| MRSA (n, %) | 2 (2.2) | 0 |
| ≥2 MDRO (n, %) | 9 (10) | 0 |
VRE indicates vancomycin-resistant enterococcus, ESBL/±FQ enterobacteriaceae with extended-spectrum b-lactamase phenotype with or without flourquinolone resistance, CRE indicates carbapenem-resistant enterobacteriaceae, MRSA methicillin-resistant staphylococcus aureus and MDRO indicates multidrug-resistant organism.